Progressive multifocal leukoencephalopathy in multiple myeloma associated with daratumumab, lenalidomide, and dexamethasone
Progressive multifocal leukoencephalopathy in multiple myeloma associated with daratumumab, lenalidomide, and dexamethasone
复制标题
与达雷妥尤单抗、来那度胺和地塞米松相关的多发性骨髓瘤进行性多灶性白质脑病
DOI:
10.1111/ncn3.12586
复制
发表时间:
2022
影响因子:
0.4
通讯作者:
Matsukawa Noriyuki
中科院分区:
文献类型:
--
作者:
Seko Kento;Uchida Yuto;Kanamori Takashi;Sakurai Keita;Usami Toshihiko;Kuno Tomoyuki;Takada Koji;Nakamichi Kazuo;Matsukawa Noriyuki
Progressive multifocal leukoencephalopathy is a rare but fatal demyelinating disease of the central nervous system with reactivation of JC virus. Herein, we describe a case of progressive multifocal leukoencephalopathy associated with a therapeutic regimen of daratumumab, lenalidomide, and dexamethasone for multiple myeloma. A 69‐year‐old man with multiple myeloma was admitted to the neurological care unit due to progressive cognitive dysfunction after seven cycles of the regimen. His CD4+T cell count was 190 cells/μL. Diffusion‐weighted magnetic resonance imaging revealed nodular diffusion restrictions in the frontal and parietal lobes. He was diagnosed with progressive multifocal leukoencephalopathy following a positive polymerase chain reaction test for JC virus DNA in the cerebrospinal fluid. After cessation of multiple myeloma treatment, his cognition and magnetic resonance imaging findings improved within 3 months. We should recognize this potentially fatal complication in patients receiving this regimen.
DOI:
10.1016/j.jns.2021.118916
发表时间:
2021
期刊:
Journal of Neurological Sciences
影响因子:
--
作者:
N. Caracciolo;L. Clemente;P. Galizia;S. Cesa;L. Prosperini;V. Cozzolino;C. Gasperini;C. Tortorella
通讯作者:
C. Tortorella